DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-11.77%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.46B
AUM Growth
+$2.46B
(-10%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
4.31%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
120
New
16
Increased
26
Reduced
21
Closed
20
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$126M |
| 2 |
Vericel Corp
VCEL
|
$36.7M |
| 3 |
Viatris
VTRS
|
$27.2M |
| 4 |
AGN
Allergan plc
AGN
|
$24.1M |
| 5 |
Aclaris Therapeutics
ACRS
|
$20.7M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$65.1M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$62.4M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$26.9M |
| 4 |
Regenxbio
RGNX
|
$20.8M |
| 5 |
Acadia Healthcare
ACHC
|
$20.7M |
Sector Composition
| 1 | Healthcare | 70.85% |
| 2 | Financials | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Glaukos
GKOS
$5.5B
| $28.3M | 1.13% | 504,000 -65,356 | -11% | -$3.67M |
|
|
BPMC
27
DELISTED
Blueprint Medicines
BPMC
| $28.1M | 1.12% | 521,000 -4,000 | -0.8% | -$216K |
|
|
RARX
28
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $27.3M | 1.09% | 1,502,000 +1,119,300 | +292% | +$20.4M |
|
29
Galapagos
GLPG
$2.07B
| $26.5M | 1.06% | 288,407 +28,343 | +11% | +$2.6M |
|
30
Editas Medicine
EDIT
$231M
| $26.4M | 1.06% | 1,158,841 | – | – |
|
|
IMMU
31
DELISTED
Immunomedics Inc
IMMU
| $26.2M | 1.05% | 1,833,202 +243,202 | +15% | +$3.47M |
|
|
DFBHU
32
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $25.3M | 1.01% | 2,500,000 | – | – |
|
33
Elevance Health
ELV
$71.8B
| $25M | 1% | 95,000 | – | – |
|
|
AGN
34
DELISTED
Allergan plc
AGN
| $24.1M | 0.96% | +180,000 | New | +$24.1M |
|
35
Fate Therapeutics
FATE
$120M
| $21.2M | 0.85% | 1,654,865 +481,248 | +41% | +$6.17M |
|
36
Select Medical
SEM
$1.61B
| $21.2M | 0.85% | 1,382,890 -143,110 | -9% | -$2.2M |
|
37
Tandem Diabetes Care
TNDM
$845M
| $21M | 0.84% | 553,765 +270,650 | +96% | +$10.3M |
|
|
RETA
38
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $20.4M | 0.82% | 364,000 +70,000 | +24% | +$3.93M |
|
|
SIEN
39
DELISTED
Sientra, Inc.
SIEN
| $20M | 0.8% | 1,572,891 +979,122 | +165% | +$12.4M |
|
40
Molina Healthcare
MOH
$9.8B
| $17.6M | 0.71% | +151,772 | New | +$17.6M |
|
41
Natera
NTRA
$23.1B
| $17.5M | 0.7% | +1,253,000 | New | +$17.5M |
|
42
Inspire Medical Systems
INSP
$2.77B
| $16.9M | 0.68% | 400,781 +211,781 | +112% | +$8.95M |
|
|
43
Acadia Healthcare
ACHC
$2.12B
| $16M | 0.64% | 621,000 -803,571 | -56% | -$20.7M |
|
44
Addus HomeCare
ADUS
$2.12B
| $15.8M | 0.63% | 232,900 +167,310 | +255% | +$11.4M |
|
|
MOR
45
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $15.2M | 0.61% | 600,000 | – | – |
|
46
KalVista Pharmaceuticals
KALV
$678M
| $12.8M | 0.51% | 650,000 | – | – |
|
|
DCPH
47
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12.8M | 0.51% | +607,633 | New | +$12.8M |
|
48
Arvinas
ARVN
$568M
| $11.8M | 0.47% | 921,234 -312,500 | -25% | -$4.02M |
|
|
GWPH
49
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10.6M | 0.43% | 109,117 +79,868 | +273% | +$7.78M |
|
|
CBAY
50
DELISTED
Cymabay Therapeutics
CBAY
| $10.6M | 0.42% | 1,343,181 | – | – |
|